HIV/AIDS Risk Assessment

These forms have been updated conceptually and technically, however, as part of the more current TCU Core Forms. Interested users are strongly encouraged to consider a customized assessments approach based on selective “packaging” of the TCU Core Forms for intake and progress evaluations.

A subset of items (3 pages) was taken from the TCU Comprehensive Intake form to assess drug use and sex related HIV risks in the past 6 months and 30 days.

TCU HIV/AIDS Risk Assessment

Also, see TCU HVHPForm, available under TCU Core Forms.

HIV/Hepatitis Risk Assessment (TCU HVHPForm) contains 17 items focused on risks associated with injection drug use (including needles and cooking works) and sexual activities, as well as health concerns and related attitudes (see Simpson, Camacho, Vogtsberger et al., 1994).

A variety of multiple-item composites and single-item outcome measures based on the AIDS Risk Assessment (ARA) have been used in studies that examine during-treatment and posttreatment changes in particular risk domains (see references listed below). Several factor analytic and configural scoring strategies have served as a basis for index construction models, yielding drug use and sex risk scales with coefficient alphas above .70. The criterion definitions as well as psychometric attributes, however, depend in part on the type of study sample involved; thus, no standardized or normative measures representing “risk levels” have been defined. Predictive validity is indicated by studies showing relationship of single and composite risk measures with cocaine use and psychosocial functioning, as well as changes in risk levels over time.

Joe, G. W., Menon, R., Copher, J. I., & Simpson, D. D. (1990, December). Needle-use and sex risk indices: A methodological report. Research in Progress: National AIDS Demonstration Research (NADR) Project. Bethesda, MD: NOVA Research Company.

Joe, G. W., Simpson, D. D., Watson, D. D., Williams, M. L., Jones, A., Vogtsberger, K. N., & Estrada, A. L. (1991, October). Composite measures of “safe” and “risky” needle use. Presented at the Third Annual Meeting of the National AIDS Demonstration Research (NADR) Project, Washington, DC.

Simpson, D. D., Copher, J. I., Vogtsberger, K. N., & Watson, D. D. (1991, October). Needle-risk changes and reliability of measures. Presented at the Third Annual Meeting of the National AIDS Demonstration Research (NADR) Project, Washington, DC.

Simpson, D. D., Knight, K., & Ray, S. (1993). Psychosocial correlates of AIDS-risk drug use and sexual behaviors. AIDS Education and Prevention, 5(2), 121-130, 1993.  [Abstract]

Joe, G. W., & Simpson, D. D. (1993). Needle use risks: Composite measures and comparisons. In B. S. Brown, G. M. Beschner, & the National AIDS Research Consortium (Eds.), Handbook on risk of AIDS: Injection drug users and sexual partners (pp. 137-154). Westport, CT: Greenwood Press.

Selected Publications

Simpson, D. D., Camacho, L. M., Vogtsberger, K. N., Williams, M. L., Stephens, R. C., Jones, A., & Watson, D. D. (1994). Reducing AIDS risks through community outreach interventions for drug injectors. Psychology of Addictive Behaviors, 8(2), 86-101.  [Abstract]

Camacho, L. M., Williams, M. L., Vogtsberger, K. N., & Simpson, D. D. (1995). Cognitive readiness of drug injectors to reduce AIDS risks. American Journal on Addictions, 4(1), 49-55.  [Abstract]

Joe, G. W., & Simpson, D. D. (1995). HIV risks, gender, and cocaine use among opioid users. Drug and Alcohol Dependence, 37, 23-28.  [Abstract]

Camacho, L. M., Brown, B. S., & Simpson, D. D. (1996). Psychological dysfunction and HIV/AIDS risk behavior. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 11, 198-202.  [Abstract]

Camacho, L. M., Bartholomew, N. G., Joe, G. W., Cloud, M. A., & Simpson, D. D. (1996). Gender, cocaine, and during-treatment HIV risk reduction among injection opiate users in methadone maintenance. Drug and Alcohol Dependence, 41, 1-7.  [Abstract]

Camacho, L. M., Bartholomew, N. G., Joe, G. W., & Simpson, D. D. (1997). Maintenance of HIV risk reduction among injection opioid users: A 12-month posttreatment follow-up. Drug and Alcohol Dependence, 47, 11-18.  [Abstract]